跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ULTRAVIST 300 Iopromide 12.468g/20mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
ULTRAVIST 300 Iopromide 12.468g/20mL injection vial
Approved
STANDARD
ULTRAVIST 300 Iopromide 12.468g/20mL injection vial
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
a7cd3d27e5d3fa9d
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
a7cd3d27e5d3fa9d
Product Name
ULTRAVIST 300 Iopromide 12.468g/20mL injection vial
Artg Id
47382
Artg Name
ULTRAVIST 300 iopromide 12.468g/20mL injection vial
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
1994-01-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/af4755250cbb1b69a5f3d43181d3438f.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/bea58b879a485a29e2cddeee327e1bee.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
a7cd3d27e5d3fa9d
Type
Standard
Back to TGA Approvals